Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boehringer Ingelheim
Pharma
Boehringer touts promising launches of Hernexeos, Jascayd
Without reporting sales figures, Boehringer Ingelheim touted its promising launches of lung disease drug Jascayd and lung cancer therapy Hernexeos.
Kevin Dunleavy
Mar 25, 2026 10:57am
Rising Stars: Chris Kraemer on the power of patient impact
Mar 4, 2026 6:00am
Pharmas stress safety, drug access amid unfolding Middle East war
Mar 2, 2026 2:20pm
Boehringer's Hernexeos earns FDA's 2nd national priority nod
Feb 26, 2026 3:22pm
Novo's Wegovy spot tops pharma Super Bowl engagement rankings
Feb 9, 2026 5:00pm
AZ, Boehringer-Simcere, Daiichi and more—Fierce Pharma Asia
Jan 30, 2026 7:45am
